Journal article

Risk factors for early death after high-dose cytosine arabinoside (HiDAC)-based chemotherapy for adult AML

A Van Der Jagt, J Muirhead, JF Seymour, KF Bradstock, E Paul, A Wei

Leukemia | Published : 2012

DOI: 10.1038/leu.2011.201

University of Melbourne Researchers

Citation metrics

4Scopus
4Web of Science
5Dimensions

Keywords

Pediatric Research Initiative
6.1 Pharmaceuticals
Prevention
Hematology
Science & Technology
Life Sciences & Biomedicine
Pediatric Cancer
32 Biomedical and Clinical Sciences
Trial
Rare Diseases
Therapy
3211 Oncology and Carcinogenesis
Childhood Leukemia
Hyperleukocytosis
Cancer
Oncology
Induction
Acute Myeloid-Leukemia